Abstract:Myocardial infarction (MI) is one of the leading causes of human mortality and morbidity. Aimed at preventing post-MI pathological left ventricular remodeling, which leads to end-stage heart failure, intramyocardial biomaterial injection was developed and has been rapidly advancing as a strategy to provide mechanical support to the ventricular wall. Various material candidates have been evaluated in clinical and preclinical trials and have presented promising therapeutic outcomes. This growing body of research has stimulated efforts to optimize material properties, identify key mechanistic factors, and implement safer, more adaptable delivery methods. We previously invented a series of poly(N-isopropylacrylamide) (polyNIPAAm) based thermally responsive injectable hydrogels which could become hydrophilic and be absorbed in vivo as labile hydrophobic polyester side chains are removed. With advantageous mechanical properties, these hydrogels has shown beneficial effects in small and large animal models of MI. At the same time, there is considerable room for improvement in material design. Hydrogel degradation rates could not be precisely manipulated across a wide range. High viscosity and sol-gel transition of hydrogel solutions below body temperature prohibited catheter based delivery. The bioactivity of the synthetic hydrogels was low, not specifically incorporating activity designed to mitigate adverse responses of MI and the injected hydrogel itself. Modifications were made on the previous hydrogel platform. We employed the concept of “acid-catalyzed degradation” documented in polyester based scaffold materials and developed an innovative strategy of tailoring the degradation rate of the hydrogel. This allowed tuning hydrogel degradation time from days to months. By copolymerization with more hydrophilic monomers, injectability of the hydrogels through catheters was substantially increased. Patterned subxiphoid transepicardial injections on a beating porcine heart were achieved facilitated by a miniature robotic delivery device. Scavengers for reactive oxygen species were incorporated into the platform design, producing an antioxidant hydrogel which significantly mitigated infarction/reperfusion injury in rat hearts and reduced ventricular cell apoptosis. In a parallel study a connective porous structure was generated in the injected hydrogel and decellularized porcine urinary bladder components were added. Cell infiltration into these hydrogels was greatly increased, and macrophages were polarized towarding a more constructive phenotype.

Trends in hydrogel-based encapsulation technologies for advanced cell therapies applied to limb ischemia

Hydrogel-based Therapeutic Angiogenesis: an Alternative Treatment Strategy for Critical Limb Ischemia.

Innovative hydrogel-based therapies for ischemia-reperfusion injury: bridging the gap between pathophysiology and treatment

Encapsulation and 3D Culture of Human Adipose-Derived Stem Cells in an In-Situ Crosslinked Hybrid Hydrogel Composed of PEG-based Hyperbranched Copolymer and Hyaluronic Acid

Cell-modified Bioprinted Microspheres for Vascular Regeneration

Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia

Hydrogel based approaches for cardiac tissue engineering

Design of a Coupled Thermoresponsive Hydrogel and Robotic System for Postinfarct Biomaterial Injection Therapy.

Stem Cell Therapy in Limb Ischemia: State-of-Art, Perspective, and Possible Impacts of Endometrial-Derived Stem Cells

Hydrogel Loaded with VEGF/TFEB‐Engineered Extracellular Vesicles for Rescuing Critical Limb Ischemia by a Dual‐Pathway Activation Strategy

Reversible Thermoresponsive Hydrogel Fabricated from Natural Biopolymer for the Improvement of Critical Limb Ischemia by Controlling Release of Stem Cells.

BIODEGRADABLE, THERMALLY RESPONSIVE HYDROGELS FOR MYOCARDIAL INFARCTION TREATMENT

Composite Hydrogel Modified by IGF-1C Domain Improves Stem Cell Therapy for Limb Ischemia.

Hydrogel-Based Therapies for Ischemic and Hemorrhagic Stroke: A Comprehensive Review

Injectable Hydrogels for Improving Cardiac Cell Therapy—In Vivo Evidence and Translational Challenges

Hydrogel Encapsulation Techniques and Its Clinical Applications in Drug Delivery and Regenerative Medicine: A Systematic Review

Injectable Alginate-Based Hydrogels Encapsulating Engineered Endothelial Extracellular Vesicles for the Treatment of Critical Limb Ischemia

Growth factor free, peptide-functionalized gelatin hydrogel promotes arteriogenesis and attenuates tissue damage in a murine model of critical limb ischemia

A Promising Application of Injectable Hydrogels in Nerve Repair and Regeneration for Ischemic Stroke

Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease

Abstract 2027: Enhancing Cell-based Therapies With Peptide-modified Thermoresponsive Citrate-based Biomaterials For Treatment Of Critical Limb Ischemia